Scientist, High-Throughput Screening
Eddie Wehri joined CEND in 2018 to help set up and run the small molecule screening lab for drug discovery. He graduated from UC Davis and started his career doing parasitology and immunology research at the Palo Alto Medical Research Foundation on Trypanosoma cruzi and Toxoplasma gondii. Later he switched to genomics working on the sequencing of the original Human Genome Project as well as comparative genomics on Chr19 at Lawrence Livermore National Labs. Finally he went into drug discovery working at Odyssey Thera and Cytokinetics doing high-throughput and high content drug discovery on a variety of targets including muscular and neuromuscular diseases. While at Cytokinetics he worked with Julia Schaletzky on several pro-bono projects stemming from academic collaborations screening for compounds against Trypanosomiasis (sleeping sickness), Malaria and Toxoplasmosis. Now he has come back full circle to work on rare and neglected diseases at UCB. In his spare time he mostly chases after a rambunctious 3 year old as well as doing some martial arts and soccer.